Relationship between oxidative stress and weakness of muscle
Relationship between oxidative stress and weakness of muscle. ROS generated from localized inflammation activate immune cells, initiating a harmful cycle characterized by the release of pro-inflammatory mediators, such as TNFα, IL-6, and CRP. Despite the presence of an impaired antioxidant system, including decreased levels of GSH and SOD, oxidative damage remains unchecked. Furthermore, inflammation disrupts mitochondrial function in muscle through the NO signaling pathway, triggering cell death via OMM permeabilization. Oxidative stress accelerates cellular senescence by activating FOXO and diminishing SIRT-1, leading to heightened MMP-9 and NF-κB activity. This escalated oxidative stress precipitates myocyte dysfunction and apoptosis, resulting in contractile dysfunction, fibrosis, hypertrophy, and impaired muscle remodeling. Additionally, there is a transition towards a type-IIx-oriented muscle phenotype with compromised oxygen distribution and utilization, ultimately impairing functionality. Abbreviations in alphabetical order: CRP—C reactive protein; FOXO—forkhead family of transcription factors; GSH—glutathione peroxidase; IL-6—Interleukin 6; MMP-9—matrix metallopeptidase 9; NF-κB—nuclear factor kappa-light-chain-enhancer of activated B cells; NO—nitrogen monoxide; OMM—outer mitochondrial membrane; RNS—reactive nitrogen species; ROS—reactive oxygen species; SIRT-1—sirtuin-1; SOD—superoxide dismutase; TNFα—tumor receptor necrosis factor alpha